Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CR-2017 improves intestinal activity/tolerance in functional gut disorders patients

May 18, 2010

Phase II safety/efficacy data on anti-IP-10 antibody in subjects with active UC presented

May 18, 2010

LA-480 inhibits HGF-dependent and independent c-Met signaling in preclinical study

May 18, 2010

ArQule presents preclinical data on novel Raf kinase B and C inhibitors

May 18, 2010

Low efficacy seen with FMP2.1/AS02A malaria vaccine in children

May 18, 2010

AIN-457 evaluated in clinical studies in patients with noninfectious uveitis

May 18, 2010

Novel Erk/PI3K inhibitors with potent preclinical activity described by AEterna Zentaris

May 18, 2010

Promising phase II data on JX-594 in HCC support phase III evaluation

May 17, 2010

VAX-102 increases immune response to trivalent influenza vaccine

May 17, 2010

Presidio reports preclinical data on its novel HCV NS5A inhibitor PPI-461

May 17, 2010

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...